(Q36168292)

12 August 2017

1 reference

title

Pharmacokinetics of hydroxyethyl starch (English)

1 reference

12 August 2017

1 reference

Cornelius Jungheinrich

series ordinal

1

1 reference

PubMed ID

15966753

12 August 2017

Thomas A Neff

series ordinal

2

1 reference

12 August 2017

1 January 2005

1 reference

Clinical Pharmacokinetics

12 August 2017

1 reference

12 August 2017

44

1 reference

12 August 2017

7

1 reference

12 August 2017

681-699

1 reference

https://scigraph.springernature.com/pub.10.2165/00003088-200544070-00002

12 August 2017

0 references

cites work

The effects of hydroxyethyl starches of varying molecular weights on platelet function

1 reference

12 December 2020

Effects of hydroxyethyl starch after trauma-hemorrhagic shock

1 reference

12 December 2020

Hydroxyethyl starch (HES) does not directly affect renal function in patients with no prior renal impairment

1 reference

12 December 2020

Volume efficacy and reduced influence on measures of coagulation using hydroxyethyl starch 130/0.4 (6%) with an optimised in vivo molecular weight in orthopaedic surgery : a randomised, double-blind study

1 reference

12 December 2020

Acetyl starch as volume substitute, a possible alternative to HES

1 reference

12 December 2020

Hydroxyethyl starch (HES) 130/0.4 provides larger and faster increases in tissue oxygen tension in comparison with prehemodilution values than HES 70/0.5 or HES 200/0.5 in volunteers undergoing acute normovolemic hemodilution

1 reference

12 December 2020

[The accumulation of different substituted hydroxyethyl starches (HES) following repeated infusions in healthy volunteers]

1 reference

12 December 2020

Large-dose hydroxyethyl starch 130/0.4 does not increase blood loss and transfusion requirements in coronary artery bypass surgery compared with hydroxyethyl starch 200/0.5 at recommended doses

1 reference

12 December 2020

Influence of intravascular molecular weight of hydroxyethyl starch on platelets.

1 reference

12 December 2020

[The elimination of hydroxyethyl starch 200/0.5, dextran 40 and oxypolygelatine (author's transl)]

1 reference

12 December 2020

Coagulation effects of a recently developed hydroxyethyl starch (HES 130/0.4) compared to hydroxyethyl starches with higher molecular weight

1 reference

12 December 2020

[Modulation of phagocytosis and endothelial function]

1 reference

12 December 2020

[The effect of different volume expanders on neutrophil granulocyte function in vitro]

1 reference

12 December 2020

RETRACTED: Influence of a new hydroxyethylstarch preparation (HES 130/0.4) on coagulation in cardiac surgical patients

1 reference

12 December 2020

Haemodilution therapy in ischaemic stroke: plasma concentrations and plasma viscosity during long-term infusion of dextran 40 or hydroxyethyl starch 200/0.5.

1 reference

12 December 2020

Studies on hydroxyethyl starch. Part II: Changes of the molecular weight distribution for hydroxyethyl starch types 450/0.7, 450/0.5, 450/0.3, 300/0.4, 200/0.7, 200/0.5, 200/0.3 and 200/0.1 after infusion in serum and urine of volunteers.

1 reference

12 December 2020

Tissue Storage of 14 C-Labelled Hydroxyethyl Starch (HES) 130/0.4 and HES 200/0.5 after Repeated Intravenous Administration to Rats

1 reference

12 December 2020

Hydroxyethylstarch as a risk factor for acute renal failure in severe sepsis

1 reference

12 December 2020

Hetastarch: An Overview of the Colloid and its Metabolism

1 reference

12 December 2020

[The effect of molecular structure of hydroxyethyl starch on the elimination kinetics and fluidity of blood in human volunteers]

1 reference

12 December 2020

Effects of hydroxyethyl starch on blood coagulation, particularly factor VIII

1 reference

12 December 2020

Studies on hydroxyethyl starch. Part I: Molecular characterization by size exclusion chromatography coupled with low-angle laser light scattering

1 reference

12 December 2020

Volume therapy with a new hydroxyethyl starch solution in cardiac surgical patients before cardiopulmonary bypass

1 reference

12 December 2020

RETRACTED: Colloids versus crystalloids and tissue oxygen tension in patients undergoing major abdominal surgery

1 reference

12 December 2020

Hydroxyethyl starch: an agent for hypovolemic shock treatment

1 reference

12 December 2020

Influence of colloid fluids on polymorphonuclear granulocyte function in vivo.

1 reference

12 December 2020

[Pharmacokinetic parameters as criteria for clinical use of hydroxyethyl starch preparations]

1 reference

12 December 2020

RETRACTED: Effects of a new modified, balanced hydroxyethyl starch preparation (Hextend) on measures of coagulation

1 reference

12 December 2020

Voluven, a lower substituted novel hydroxyethyl starch (HES 130/0.4), causes fewer effects on coagulation in major orthopedic surgery than HES 200/0.5.

1 reference

12 December 2020

Hydroxyethyl starch (HES) [130/0.4], a new HES specification: pharmacokinetics and safety after multiple infusions of 10% solution in healthy volunteers

1 reference

12 December 2020

Hydroxyethyl starch does not impair immediate renal function in kidney transplant recipients: a retrospective, multicentre analysis

1 reference

12 December 2020

The pharmacokinetics and tolerability of an intravenous infusion of the new hydroxyethyl starch 130/0.4 (6%, 500 mL) in mild-to-severe renal impairment

1 reference

12 December 2020

Pharmacokinetics and Tolerability of a New Hydroxyethyl Starch (HES) Specification [HES (130/0.4)] after Single-Dose Infusion of 6% or 10% Solutions in Healthy Volunteers

1 reference

12 December 2020

The influence of different intravascular volume replacement regimens on renal function in the elderly.

1 reference

12 December 2020

Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study.

1 reference

12 December 2020

Evaluation of a new hydroxyethyl starch solution (HES 130/0.4) in patients undergoing preoperative autologous blood donation

1 reference

12 December 2020

Plasma substitution effects of a new hydroxyethyl starch HES 130/0.4 compared with HES 200/0.5 during and after extended acute normovolaemic haemodilution

1 reference

12 December 2020

Hydroxyethyl starch in balanced electrolyte solution (Hextend)--pharmacokinetic and pharmacodynamic profiles in healthy volunteers

1 reference

12 December 2020

Tissue deposits of hydroxyethyl starch (HES): dose-dependent and time-related

1 reference

12 December 2020

Intestinal elimination of hydroxyethyl starch?

1 reference

12 December 2020

HES 200/0.5 is not HES 200/0.5. Influence of the C2/C6 hydroxyethylation ratio of hydroxyethyl starch (HES) on hemorheology, coagulation and elimination kinetics.

1 reference

12 December 2020

The effect of 6% hydroxyethyl starch 450/0.7, 10% dextran 40 and 3.5% gelatin on plasma volume in patients with terminal renal failure (author's transl)

1 reference

12 December 2020

A clinical physiologic study of hydroxyethyl starch

1 reference

12 December 2020

Repetitive Large-Dose Infusion of the Novel Hydroxyethyl Starch 130/0.4 in Patients with Severe Head Injury

1 reference

12 December 2020

RETRACTED: Kidney-specific proteins in elderly patients undergoing cardiac surgery with cardiopulmonary bypass

1 reference

12 December 2020

Pharmacokinetics of Hydroxyethyl Starch in Normal Subjects

1 reference

12 December 2020

RETRACTED: The influence of intravascular volume therapy with a new hydroxyethyl starch preparation (6% HES 130/0.4) on coagulation in patients undergoing major abdominal surgery

1 reference

12 December 2020

Hydroxyethyl starch and change in renal function in patients undergoing coronary artery bypass graft surgery

1 reference

12 December 2020

Plasma volume changes associated with two hydroxyethyl starch colloids following acute hypovolaemia in volunteers

1 reference

12 December 2020

A novel hydroxyethyl starch (Voluven) for effective perioperative plasma volume substitution in cardiac surgery.

1 reference

12 December 2020

All medium starches are not the same: influence of the degree of hydroxyethyl substitution of hydroxyethyl starch on plasma volume, hemorrheologic conditions, and coagulation

1 reference

12 December 2020

Intravascular Persistence of Hydroxyethyl Starch in Man

1 reference

12 December 2020

Exact measurement of the volume effect of 6% hydoxyethyl starch 130/0.4 (Voluven) during acute preoperative normovolemic hemodilution

1 reference

12 December 2020

In vitro effects of different medium molecular hydroxyethyl starch solutions and lactated Ringer's solution on coagulation using SONOCLOT

1 reference

12 December 2020

High doses of hydroxyethyl starch and human albumin have similar effects on monocyte function and oncotic pressure

1 reference

12 December 2020

Intravascular volume replacement therapy with synthetic colloids: is there an influence on renal function?

1 reference

12 December 2020

Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients.

1 reference

12 December 2020

10.2165/00003088-200544070-00002

Identifiers

DOI

1 reference

PubMed ID

15966753

Dimensions Publication ID

12 August 2017

0 references

1 reference

PubMed ID

15966753